Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0
|
作者：
Willem R. Pieters
Bo Lundbäck
Seema Sondhi
Martin J. Price
Robert M.A. Thwaites
机构：
[1] Elkerliek Ziekenhuis,Respiratory Unit
[2] National Institute for Working Life,Global Health Outcomes
[3] Glaxo Wellcome,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.
引用
收藏
页码：29 / 34
页数：5
相关论文
共 50 条
  • [21] Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma
    O'Connor, RD
    Nelson, H
    Borker, R
    Emmett, A
    Jhingran, P
    Rickard, K
    Dorinsky, P
    PHARMACOECONOMICS, 2004, 22 (12) : 815 - 825
  • [22] Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
    Ferguson, Gary T.
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Knobil, Katharine
    Kalberg, Christopher
    RESPIRATORY MEDICINE, 2008, 102 (08) : 1099 - 1108
  • [23] Cost-effectiveness analysis of fluticasone propionate/salmeterol combination versus montelukast in the treatment of adults with asthma
    Leibman, C
    Pathak, D
    Bowers, B
    Dorinsky, PM
    Pepsin, P
    Kalberg, C
    Emmett, A
    Rickard, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S185 - S185
  • [24] CLINICAL EFFECTIVENESS AND COST IMPACT OF INITIATING OR CHANGING TO FLUTICASONE PROPIONATE/FORMOTEROL VERSUS TREATMENT WITH FLUTICASONE PROPIONATE/SALMETEROL IN UK PATIENTS WITH ASTHMA
    Yau, Simon
    Small, Iain
    Wolfe, Stephanie
    Hamil, John
    Gruffydd-Jones, Kevin
    Daly, Cathal
    Price, David
    RESPIROLOGY, 2015, 20 : 19 - 19
  • [25] Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma.
    Shapiro, G
    Lumry, W
    Wolfe, J
    Given, J
    White, MV
    Woodring, A
    Baitinger, L
    House, K
    Prillaman, B
    Shah, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) : 527 - 534
  • [26] The efficacy and safety of combination salmeterol (50 μg)/fluticasone propionate (500 μg) inhalation twice daily via accuhaler in Chinese patients with COPD
    Zheng, Jin-Ping
    Yang, Lan
    Wu, Ya Mei
    Chen, Ping
    Wen, Zhong Guang
    Huang, Wen-Jie
    Shi, Yi
    Wang, Chang-Zheng
    Huang, Shao-Guang
    Sun, Tie-ying
    Wang, Guang-Fa
    Xiong, Sheng-Dao
    Zhong, Nan-Shan
    CHEST, 2007, 132 (06) : 1756 - 1763
  • [27] Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100μg bd versus fluticasone propionate 100μg bd alone in patients with persistent asthma:: Integrated analysis of four randomised trials
    Barnes, N. C.
    Jacques, L.
    Goldfrad, C.
    Bateman, E. D.
    RESPIRATORY MEDICINE, 2007, 101 (11) : 2358 - 2365
  • [28] Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma
    Sheth, K
    Borker, R
    Emmett, A
    Rickard, K
    Dorinsky, P
    PHARMACOECONOMICS, 2002, 20 (13) : 909 - 918
  • [29] A comparison of fluticasone propionate 250 μg/day with beclomethasone dipropionate 500 μg/day in adult asthma
    Radulovic, S
    Stankovic, I
    ALLERGY, 2002, 57 : 340 - 340
  • [30] Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma
    Ketan Sheth
    Rohit Borker
    Amanda Emmett
    Kathleen Rickard
    Paul Dorinsky
    PharmacoEconomics, 2002, 20 : 909 - 918
12345